TotalMarketCap

Exagen

XGNNasdaq United StatesHealth CareMedical Specialities

Market cap

$181.448 M

$7.49 -11.99%

Close of 6 Nov 2026

As of 6 Nov 2026, Exagen (XGN) has a market capitalization of $181.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$66.6M

#2624 by revenue

Earnings

-$20.0M

Loss-making

Shares outstanding

24,225,339

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #33TriSalus Life SciencesTLSI$217.4M
  2. #34BiodesixBDSX$211.0M
  3. #35ExagenXGN$181.4M
  4. #36Burning Rock BiotechBNR$139.2M
  5. #37Kewaunee ScientificKEQU$98.0M

What if Exagen were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,165,593

Per share 155,620× higher

Bitcoin $1.53T

$63,068.18

Per share 8,420× higher

Apple $5.02T

$207,046.95

Per share 27,643× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Exagen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.